JGIA
OGN icon

Jackson Grant Investment Advisers’s Organon & Co OGN Stock Holding History

Jackson Grant Investment Advisers’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-360
Closed -$11K – 357
2021
Q4 		$11K Sell
360
-44
-11% -$1.43K 0.01% 265
2021
Q3 		$13K Sell
404
-671
-62% -$21.5K 0.01% 317
2021
Q2 		$33K Buy
+1,075
New +$35.4K 0.01% 246

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jackson Grant Investment Advisers's OGN Position: Q1 2022 in Review

Jackson Grant Investment Advisers sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 360 shares — an estimated $11K sold.

Jackson Grant Investment Advisers first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $33K in Q2 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

  • Jackson Grant Investment Advisers reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
  • Jackson Grant Investment Advisers sold 360 Organon & Co shares in Q1 2022, an estimated $11K.
  • Jackson Grant Investment Advisers first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
  • Jackson Grant Investment Advisers's Organon & Co position peaked at $33K in Q2 2021.
  • 818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Jackson Grant Investment Advisers's 13F filing for Q1 2022, filed 28 Apr 2022.